Which retinoblastoma patients should be screened for RB1 mutations?

DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter.

Epigenetics·2020

Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.

Oncogene·2016

WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling.

Oncogene·2016

Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.

Oncogene·2015

Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.

Journal francais d'ophtalmologie·2015

Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.

Oncogene·2015

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

European journal of cancer (Oxford, England : 1990)·2026

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

European journal of cancer (Oxford, England : 1990)·2026

Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

European journal of cancer (Oxford, England : 1990)·2026

Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

European journal of cancer (Oxford, England : 1990)·2026

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

European journal of cancer (Oxford, England : 1990)·2026

Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

European journal of cancer (Oxford, England : 1990)·2026

Delayed Diabetes Treatment and Persistent Hyperglycemia among Individuals with Schizophrenia: a Nationwide Register-Based Study.

Schizophrenia bulletin·2026

Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.

Journal of visualized experiments : JoVE·2026

An Engineering-Editable Hybrid Membrane‑Camouflaged DNA Origami Drug Enables Checkpoint Blockade and Immune Activation for Triple-Negative Breast Cancer Immunotherapy.

Angewandte Chemie (International ed. in English)·2026

Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Restoration of m6A-Modified circPSMB1 Suppresses Chordoma Progression and Enables Local Nanotherapeutic Intervention.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Dietary-Derived Corchorus olitorius L. Extract Suppresses KRAS-Mutant Pancreatic Cancer by Activating Ferritinophagy-Dependent Ferroptosis.

Journal of food science·2026

Related Experiment Videos

Which retinoblastoma patients should be screened for RB1 mutations?

Related Concept Videos

DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter.

Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.

WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling.

Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.

Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.

Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

Delayed Diabetes Treatment and Persistent Hyperglycemia among Individuals with Schizophrenia: a Nationwide Register-Based Study.

Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.

An Engineering-Editable Hybrid Membrane‑Camouflaged DNA Origami Drug Enables Checkpoint Blockade and Immune Activation for Triple-Negative Breast Cancer Immunotherapy.

Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.

Restoration of m6A-Modified circPSMB1 Suppresses Chordoma Progression and Enables Local Nanotherapeutic Intervention.

Dietary-Derived Corchorus olitorius L. Extract Suppresses KRAS-Mutant Pancreatic Cancer by Activating Ferritinophagy-Dependent Ferroptosis.

Related Experiment Videos

Which retinoblastoma patients should be screened for RB1 mutations?

Related Concept Videos

Related Articles